Education
- Master of Clinical Pharmacology, King’s College London, Sep 2022 - Sep 2023
- Main courses: Good Clinical Practice, Data Management, Pharmaceutics, Pharmacokinetics and Pharmacodynamics
- Bachelor of Pharmacy, China Pharmaceutical University, Mar 2019 - Jan 2022
- Main courses: Physiology, Pathophysiology, Biochemistry, Microbiology, Natural Pharmacochemistry, Medicinal Chemistry, Pharmaceutical Analysis, Pharmacology, Pharmacy
Work Experience
- Pharmacist, Wuxi Maternity and Child Healthcare Hospital, Wuxi, China, Jul 2018 - Present
- Currently serving as a Clinical Trial Quality Assurance Officer at the hospital’s Drug Clinical Trial Center
- Managed therapeutic drug monitoring and participated in multiple pharmacogenomic clinical intervention trials
- Secretary, Pharmaceutical Policy Professional Committee of Wuxi Pharmacists Association, Wuxi, China, Oct 2023 - Present
- Coordinate drug policy meetings and handle policy recommendations from pharmacy experts to the government health departments
Projects
- Development of high-sensitivity EpCAM and MUC-1 Aptasensor for early diagnosis of breast cancer based on Carboxylic MXene, May 2023 – Aug 2023
- Master’s Thesis
- Systematically optimized critical parameters to enhance the sensitivity of the Aptasensor for the detection of EpCAM proteins and exosomes
- The aptasensor demonstrated a large detection range and a low limit of detection
- Utilization of MTHFR Genetic Polymorphism Screening for Tailored Folic Acid Supplementation Strategies in Pregnant Women, Jul 2020 – Nov 2024
- Hospital Research Topic
- Utilized genetic polymorphism testing to stratify the risk of neural tube defects in infants
- Ensured adequate doses of folate through personalized active folate supplementation and lifestyle guidance
- Independently developed a results query system and secured two invention patents in collaboration with colleagues
- Investigation into the Polymorphism of the ESR1 Gene as a Predictive Marker for Osteoporosis in Breast Cancer Patients Undergoing Prolonged Therapy with Third-Generation Aromatase Inhibitors, Mar 2020 – Sep 2023
- Hospital Research Topic
- Examined the estrogen receptor (ESR1) gene polymorphisms in breast cancer patients
- Collaborated with physicians and nutritionists to stratify patients based on their ESR1 genetic polymorphisms
- Reduced the risk of osteoporosis in more than 200 postmenopausal breast cancer patients undergoing tamoxifen treatment
Qualifications
- Certificate Licensed Pharmacist, Nov 2021 – Present
- Certificate Good Clinical Practice, Oct 2023 – Present
Awards
- The First Prize of The 5th Hospital Quality Control Circle Competition, Jiangsu Province Hospital Association, 30/08/2021
- The Bronze Prize of Results Reporting Conference on Pharmaceutical Quality Management Activities in Jiangsu Provincial Hospitals, Jiangsu Pharmaceutical Association, 14/11/2020
- The Third Prize of The 2nd Medicine And Health Science China Tour, Southern Region, Chinese Pharmacists Association and China Health Promotion Foundation, 25/09/2020
- The First Prize of Results Reporting Conference on Pharmaceutical Quality Management Activities in Wuxi Hospitals, Wuxi Pharmaceutical Association, 16/09/2020
Patents
- Sample pretreatment device for folate gene and folate concentration determination, CN212988971U
- Cryogenic sample bottle, CN215063055U
Abilities
- Laboratory skills: HPLC, Flow cytometry, PCR, Electrochemical sensor development
- Programming: Origin, LaTeX, Markdown, Github, R
- Communication: Chinese (Native), English (C1)